| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019505753 |
| P356 | DOI | 10.1038/SJ.GT.3301320 |
| P698 | PubMed publication ID | 11127579 |
| P5875 | ResearchGate publication ID | 12200484 |
| P2093 | author name string | Shimizu K | |
| Sakamoto T | |||
| Ohashi H | |||
| Hisatomi T | |||
| Inomata H | |||
| Ueno H | |||
| Sonoda K | |||
| P2860 | cites work | Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 |
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| Transforming growth factor beta in tissue fibrosis | Q28239292 | ||
| Markers of mouse macrophage development detected by monoclonal antibodies | Q28247978 | ||
| Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
| Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review | Q35482860 | ||
| Release of TGF-beta 1 and VEGF in tears following photorefractive keratectomy | Q36847777 | ||
| Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. | Q37182998 | ||
| Immunomodulation by mucosal gene transfer using TGF-beta DNA. | Q37383991 | ||
| Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. | Q37567229 | ||
| Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis | Q39762254 | ||
| Macrophages and angiogenesis | Q40386885 | ||
| Significance of angiogenesis in tumour progression and metastasis | Q40423643 | ||
| Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration | Q40761450 | ||
| Retinal functional change caused by adenoviral vector-mediated transfection of LacZ gene | Q40859832 | ||
| Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects | Q40922411 | ||
| Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries | Q40965587 | ||
| Adenoviruses as gene-delivery vehicles | Q40970776 | ||
| Adenovirus-mediated gene transfer to the ocular surface epithelium | Q40983395 | ||
| Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor | Q41044204 | ||
| Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture | Q41186218 | ||
| Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro | Q41205208 | ||
| Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface | Q42490603 | ||
| Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only | Q42495897 | ||
| Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration | Q47957048 | ||
| The macrophage cell surface glycoprotein F4/80 is a highly glycosylated proteoglycan | Q71118216 | ||
| Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia | Q72331358 | ||
| An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct | Q72411299 | ||
| Transforming growth factor-beta1 expression in cultured corneal fibroblasts in response to injury | Q73561790 | ||
| P433 | issue | 22 | |
| P304 | page(s) | 1915-1924 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis | |
| P478 | volume | 7 |
| Q34389392 | An intracameral injection of antigen induces in situ chemokines and cytokines required for the generation of circulating immunoregulatory monocytes |
| Q36342390 | Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye. |
| Q36339566 | Anti-TGF-beta strategies for the treatment of chronic liver disease |
| Q34451949 | Anticytokine gene therapy of autoimmune diseases |
| Q33909025 | Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries |
| Q37179025 | Developmental regulation of myeloerythroid progenitor function by the Lin28b-let-7-Hmga2 axis |
| Q34416392 | Gene targeting to the retina |
| Q44128315 | Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy. |
| Q34382370 | IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1 |
| Q45122645 | Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice |
| Q33723271 | Medical applications of transforming growth factor-beta |
| Q45869374 | Modulation of renal glomerular disease using remote delivery of adenoviral‐encoded solubletype II TGF‐β receptor fusion molecule |
| Q51356338 | Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane. |
| Q31045998 | Nitric oxide is proangiogenic in the retina and choroid. |
| Q37681157 | Novel aspects of corneal angiogenic and lymphangiogenic privilege. |
| Q40277998 | Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene |
| Q36829075 | Stem Cells in the Limbal Stroma |
| Q36337915 | TGFbeta pathobiology in the eye. |
| Q37080979 | The pathogenesis of pterygium: current concepts and their therapeutic implications. |
| Q37786166 | Transforming Growth Factor β Signal Transduction: A Potential Target for Maintenance/Restoration of Transparency of the Cornea |
| Q50956673 | Treatment of corneal defects with delayed re-epithelization with a medical device/drug delivery system for epidermal growth factor. |
Search more.